Linda Mileshkin, MD, PhD

Linda Mileshkin, MD, PhD
Professor Linda Mileshkin (Australia) is a medical oncologist and a clinical researcher with a particular interest in the treatment of gynecologic cancers, as well as the supportive care of people affected by cancer. She also runs Australia’s only specialist clinic dedicated to the care of people affected by Cancer of Unknown Primary (CUP). She is the Director of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia, as well as the clinical trials lead for Gynae-Oncology in the Parkville Cancer Clinical Trials Unit. She has both led and collaborated in multiple practice-changing international and national trials, particularly involving adjuvant therapies in gynecologic cancer. She is also very involved in the Australia New Zealand Gynaecological Oncology Group (ANZGOG) as a member of multiple committees and Chair of the EDEN initiative which aims to improve outcomes for women with Endometrial cancer.

Saketh R. Guntupalli, MD

Saketh R. Guntupalli, MD
Saketh R. Guntupalli, MD (United States) is Professor and Director of the Division of Gynecologic Oncology at the University of Colorado School of Medicine at Denver and holds the Karen M. Jennison Endowed Chair in Gynecologic Oncology . He received his undergraduate degree from the Johns Hopkins University and his medical degree from the University of Texas at Houston. After a 4-year residency in obstetrics and gynecology at Baylor College of Medicine in Houston, Dr. Guntupalli completed an additional 3-year surgical fellowship in gynecologic oncology and advanced pelvic surgery at Washington University in St. Louis.

Dr. Guntupalli is a leading national and international expert in women's cancer and has lectured all over the world on surgical expertise and molecular mechanisms of cancer. He has authored over 100 clinical papers and has led multiple collaborative research studies focused on improving post-operative surgical outcomes as well as identifying novel therapies for the treatment of ovarian and uterine cancer. With over $5,000,000 in independent research funding, Dr. Guntupalli has previously led the NRG collaborative research consortium at the University of Colorado Cancer Center for nearly 4 years. Dr. Guntupalli has as an additional expertise in sexual dysfunction broadly in cancer patients and has authored a New York Times reviewed book and multiple editorials in Forbes. He serves on multiple national committees including the past Chair of Legislative Affairs for the Society of Gynecologic Oncology and has served on numerous program committees for IGCS.

Michael Pearl, MD

Michael Pearl, MD
Dr. Michael Pearl (United States) is Professor of Gynecologic Oncology and Vice-Chairman for Research in the Department of Obstetrics, Gynecology & Reproductive Medicine at Stony Brook Medicine. He is the Leader of Gynecologic Oncology Disease Management and Clinical Research Teams, Medical Director of the Clinical Trials Office and Director of Women’s Cancer Services for the Cancer Center. He is board certified in Obstetrics and Gynecology, Gynecologic Oncology, and Hospice and Palliative Medicine. He is a member of the American College of Obstetricians and Gynecologists, American College of Surgeons, the Society of Gynecologic Oncology, The International Gynecologic Cancer Society and the American Academy of Hospice and Palliative Medicine. In addition to his clinical activities, Dr. Pearl is one of the chairs of Stony Brook University’s Committee on Research in Human Subjects. He is the Principal Investigator at Stony Brook Medicine for NRG Oncology and contact PI for several regional NRG affiliates. He is the current IGCS Education Committee Vice Chair and ex officio Co-Chair of the Annual Global Meeting Program Committee. Dr. Pearl has authored over a hundred articles and book chapters in his field and serves as a reviewer for multiple journals.